Vitrolife AB VITR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 165.30
- Day Range
- SEK 161.30–167.40
- 52-Week Range
- SEK 123.90–244.20
- Bid/Ask
- SEK 161.50 / SEK 161.90
- Market Cap
- SEK 22.05 Bil
- Volume/Avg
- 71,385 / 118,452
Key Statistics
- Price/Earnings (Normalized)
- 34.26
- Price/Sales
- 6.40
- Dividend Yield (Trailing)
- 0.51%
- Dividend Yield (Forward)
- 0.61%
- Total Yield
- 0.51%
Company Profile
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient’s fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,116
- Website
- https://www.vitrolife.com
Comparables
Valuation
|
Metric
|
VITR
|
EKTA B
|
GETI B
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.26 | 17.66 | 26.36 |
Price/Book Value | 1.69 | 2.80 | 1.95 |
Price/Sales | 6.40 | 1.57 | 1.96 |
Price/Cash Flow | 24.92 | 10.43 | 13.82 |
Price/Earnings
VITR
EKTA B
GETI B
Financial Strength
|
Metric
|
VITR
|
EKTA B
|
GETI B
|
|---|---|---|---|
Quick Ratio | 2.30 | 0.82 | 1.00 |
Current Ratio | 3.06 | 1.09 | 1.69 |
Interest Coverage | 6.45 | 7.21 | 9.13 |
Quick Ratio
VITR
EKTA B
GETI B
Profitability
|
Metric
|
VITR
|
EKTA B
|
GETI B
|
|---|---|---|---|
Return on Assets (Normalized) | 1.99% | 4.76% | 4.79% |
Return on Equity (Normalized) | 2.43% | 14.30% | 8.20% |
Return on Invested Capital (Normalized) | 2.54% | 10.01% | 7.34% |
Return on Assets
VITR
EKTA B
GETI B
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Plpkhsq | Mbrrj | $185.5 Bil | |
SYK
| Stryker Corp | Wnpvwsns | Cslt | $127.4 Bil | |
MDT
| Medtronic PLC | Lqzcwhh | Lybclvy | $106.7 Bil | |
BSX
| Boston Scientific Corp | Wfcyngzzz | Nvjvnd | $99.0 Bil | |
DXCM
| DexCom Inc | Fzpkjsfjt | Glwz | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Jyrdjgxjs | Gmvgrt | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Pmdkmwgpff | Kmqg | $25.0 Bil | |
ALGN
| Align Technology Inc | Yzcvtxkny | Tvvbkb | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Nzgnpyy | Tsfcxt | $18.9 Bil | |
PODD
| Insulet Corp | Kjstkrzkh | Mzdnrkp | $11.7 Bil |